Because expression of several aaRS and aaRS2 genes is decreased in FRDA cells, a cumulative effect of their deficiency, either directly related to the pool of aa-tRNAs available or other as-yet uncovered functions of these enzymes, can affect the clinical presentation of FRDA patients. The gene discussed is AARS2; the disease is Friedreich ataxia.